当前位置:首页 - 行情中心 - 国际医学(000516) - 财务分析 - 现金流量表

国际医学

(000516)

  

流通市值:113.77亿  总市值:115.53亿
流通股本:22.05亿   总股本:22.39亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,200,827,393.691,042,748,064.224,769,065,473.293,523,688,510.75
  收到的税费返还318,160.42314,844.59-608,388.18
  收到其他与经营活动有关的现金34,402,519.6233,542,822.8270,741,461.4920,292,206.18
  经营活动现金流入小计2,235,548,073.731,076,605,731.634,839,806,934.783,544,589,105.11
  购买商品、接受劳务支付的现金751,796,285.47309,389,408.822,026,976,378.721,529,422,169.84
  支付给职工以及为职工支付的现金765,828,105.56429,624,052.481,527,265,013.651,182,670,809.57
  支付的各项税费34,629,588.620,336,348.2579,340,046.5460,868,447.2
  支付其他与经营活动有关的现金90,752,130.0573,451,762.72197,105,682.66147,940,562.63
  经营活动现金流出小计1,643,006,109.68832,801,572.273,830,687,121.572,920,901,989.24
  经营活动产生的现金流量净额592,541,964.05243,804,159.361,009,119,813.21623,687,115.87
二、投资活动产生的现金流量:
  收回投资收到的现金87,768,127.8277,768,127.8250,000,00050,000,000
  取得投资收益收到的现金440,751.07426,741.572,056,423.032,040,463.63
  处置固定资产、无形资产和其他长期资产收回的现金净额1,800-495,98615,000
  投资活动现金流入小计88,210,678.8978,194,869.3952,552,409.0352,055,463.63
  购建固定资产、无形资产和其他长期资产支付的现金206,982,673.01149,382,648.02547,740,389.83458,211,576.8
  投资支付的现金500,000500,00011,000,000-
  投资活动现金流出小计207,482,673.01149,882,648.02558,740,389.83458,211,576.8
  投资活动产生的现金流量净额-119,271,994.12-71,687,778.63-506,187,980.8-406,156,113.17
三、筹资活动产生的现金流量:
  取得借款收到的现金203,010,00099,980,000717,480,000557,630,000
  筹资活动现金流入小计203,010,00099,980,000717,480,000557,630,000
  偿还债务支付的现金822,251,754.84349,932,666.641,372,157,458.681,083,234,010.98
  分配股利、利润或偿付利息支付的现金80,753,108.7941,122,335.56183,716,799.66148,468,474.61
  支付其他与筹资活动有关的现金56,024,709.8660,000,00059,938,209.5159,938,209.51
  筹资活动现金流出小计959,029,573.49451,055,002.21,615,812,467.851,291,640,695.1
  筹资活动产生的现金流量净额-756,019,573.49-351,075,002.2-898,332,467.85-734,010,695.1
五、现金及现金等价物净增加额-282,749,603.56-178,958,621.47-395,400,635.44-516,479,692.4
  加:期初现金及现金等价物余额548,562,003.38548,562,003.38943,962,638.82943,962,638.82
  期末现金及现金等价物余额265,812,399.82369,603,381.91548,562,003.38427,482,946.42
补充资料:
  净利润-218,312,970.23--365,139,719.05-
  固定资产和投资性房地产折旧327,431,413.35-689,427,358.89-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧327,431,413.35-689,427,358.89-
  无形资产摊销17,285,154.42-41,117,189.92-
  长期待摊费用摊销8,563,798.48-14,610,878.66-
  处置固定资产、无形资产和其他长期资产的损失---1,655,587.15-
  固定资产报废损失152,928.83-2,590,880.12-
  公允价值变动损失-2,320,448.33--25,370,529.61-
  财务费用74,534,722.28-173,353,108.43-
  投资损失-20,940,436.87-1,600,542.89-
  递延所得税229,237.98-9,823,661.85-
  其中:递延所得税资产减少229,237.98-9,223,661.85-
    递延所得税负债增加--600,000-
  存货的减少20,123,557.12--2,668,133.56-
  经营性应收项目的减少59,756,220.96--133,051,137.45-
  经营性应付项目的增加333,647,064.13-589,744,614.49-
  其他--6,660,751.11-
  现金的期末余额265,812,399.82-548,562,003.38-
  减:现金的期初余额548,562,003.38-943,962,638.82-
  现金及现金等价物的净增加额-282,749,603.56--395,400,635.44-
公告日期2025-08-222025-04-232025-04-232024-10-25
审计意见(境内)标准无保留意见
TOP↑